Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael I Sponfeldner

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Clinical Pharmacology and Therapeutics|July 11, 2024
Pseudo-Worsening of Kidney Function Due to Inhibition of Renal Creatinine Secretion: Quality of Information Provided in Prescribing Information/SmPCMichael I Sponfeldner, Wahram Andrikyan, Renke Maas, et al.
British Journal of Clinical Pharmacology|November 8, 2024
Physicians' and pharmacists' perspective on clarity and clinical relevance of absolute contraindications in "Summaries of Product Characteristics"Wahram Andrikyan, Michael I Sponfeldner, Lea Jung-Poppe, et al.
Clinical Pharmacology and Therapeutics|December 22, 2025
Extent and Incidence of Pseudo-Worsening of Kidney Function Due to Oral Antitumor Therapeutics in the AMBORA Cohort: An Analysis of Real-World DataMichael I Sponfeldner, Pauline Dürr, Phyllis Lensker, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Clinical Pharmacology and Therapeutics|July 11, 2024
Pseudo-Worsening of Kidney Function Due to Inhibition of Renal Creatinine Secretion: Quality of Information Provided in Prescribing Information/SmPCMichael I Sponfeldner, Wahram Andrikyan, Renke Maas, et al.
British Journal of Clinical Pharmacology|November 8, 2024
Physicians' and pharmacists' perspective on clarity and clinical relevance of absolute contraindications in "Summaries of Product Characteristics"Wahram Andrikyan, Michael I Sponfeldner, Lea Jung-Poppe, et al.
Clinical Pharmacology and Therapeutics|December 22, 2025
Extent and Incidence of Pseudo-Worsening of Kidney Function Due to Oral Antitumor Therapeutics in the AMBORA Cohort: An Analysis of Real-World DataMichael I Sponfeldner, Pauline Dürr, Phyllis Lensker, et al.
Pageof 1